In vitro blood cell viability profiling of polymers used in molecular assembly

Hyejoong Jeong, Jangsun Hwang, Hwankyu Lee, Paula T. Hammond, Jonghoon Choi, Jinkee Hong

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Biocompatible polymers have been extensively applied to molecular assembly techniques on a micro- A nd nanoscale to miniaturize functional devices for biomedical uses. However, cytotoxic assessments of developed devices are prone to partially focus on non-specific cells or cells associated with the specific applications. Thereby, since toxicity is dependent on the type of cells and protocols, we do not fully understand the relative toxicities of polymers. Additionally, we need to ensure the blood cell biocompatibility of developed devices prior to that of targeted cells because most of the devices contact the blood before reaching the targeted regions. Motivated by this issue, we focused on screening cytotoxicity of polymers widely used for the layer-by-layer assembly technique using human blood cells. Cytotoxicity at the early stage was investigated on twenty types of polymers (positively charged, negatively charged, or neutral) and ten combination forms via hemolysis, cell viability, and AnnexinV-FITC/PI staining assays. We determined their effects on the cell membrane depending on their surface chemistry by molecular dynamics simulations. Furthermore, the toxicity of LbL-assembled nanofilms was assessed by measuring cell viability. Based on this report, researchers can produce nanofilms that are better suited for drug delivery and biomedical applications by reducing the possible cytotoxicity.

Original languageEnglish
Article number9481
JournalScientific reports
Volume7
Issue number1
DOIs
Publication statusPublished - 2017 Dec 1

Fingerprint

Polymers
Blood
Cytotoxicity
Cells
Toxicity
Fluorescein-5-isothiocyanate
Cell membranes
Surface chemistry
Drug delivery
Biocompatibility
Molecular dynamics
Assays
Screening
Computer simulation

All Science Journal Classification (ASJC) codes

  • General

Cite this

Jeong, Hyejoong ; Hwang, Jangsun ; Lee, Hwankyu ; Hammond, Paula T. ; Choi, Jonghoon ; Hong, Jinkee. / In vitro blood cell viability profiling of polymers used in molecular assembly. In: Scientific reports. 2017 ; Vol. 7, No. 1.
@article{ad6b881d8f844b2f8a1d964ae647d70a,
title = "In vitro blood cell viability profiling of polymers used in molecular assembly",
abstract = "Biocompatible polymers have been extensively applied to molecular assembly techniques on a micro- A nd nanoscale to miniaturize functional devices for biomedical uses. However, cytotoxic assessments of developed devices are prone to partially focus on non-specific cells or cells associated with the specific applications. Thereby, since toxicity is dependent on the type of cells and protocols, we do not fully understand the relative toxicities of polymers. Additionally, we need to ensure the blood cell biocompatibility of developed devices prior to that of targeted cells because most of the devices contact the blood before reaching the targeted regions. Motivated by this issue, we focused on screening cytotoxicity of polymers widely used for the layer-by-layer assembly technique using human blood cells. Cytotoxicity at the early stage was investigated on twenty types of polymers (positively charged, negatively charged, or neutral) and ten combination forms via hemolysis, cell viability, and AnnexinV-FITC/PI staining assays. We determined their effects on the cell membrane depending on their surface chemistry by molecular dynamics simulations. Furthermore, the toxicity of LbL-assembled nanofilms was assessed by measuring cell viability. Based on this report, researchers can produce nanofilms that are better suited for drug delivery and biomedical applications by reducing the possible cytotoxicity.",
author = "Hyejoong Jeong and Jangsun Hwang and Hwankyu Lee and Hammond, {Paula T.} and Jonghoon Choi and Jinkee Hong",
year = "2017",
month = "12",
day = "1",
doi = "10.1038/s41598-017-10169-5",
language = "English",
volume = "7",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

In vitro blood cell viability profiling of polymers used in molecular assembly. / Jeong, Hyejoong; Hwang, Jangsun; Lee, Hwankyu; Hammond, Paula T.; Choi, Jonghoon; Hong, Jinkee.

In: Scientific reports, Vol. 7, No. 1, 9481, 01.12.2017.

Research output: Contribution to journalArticle

TY - JOUR

T1 - In vitro blood cell viability profiling of polymers used in molecular assembly

AU - Jeong, Hyejoong

AU - Hwang, Jangsun

AU - Lee, Hwankyu

AU - Hammond, Paula T.

AU - Choi, Jonghoon

AU - Hong, Jinkee

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Biocompatible polymers have been extensively applied to molecular assembly techniques on a micro- A nd nanoscale to miniaturize functional devices for biomedical uses. However, cytotoxic assessments of developed devices are prone to partially focus on non-specific cells or cells associated with the specific applications. Thereby, since toxicity is dependent on the type of cells and protocols, we do not fully understand the relative toxicities of polymers. Additionally, we need to ensure the blood cell biocompatibility of developed devices prior to that of targeted cells because most of the devices contact the blood before reaching the targeted regions. Motivated by this issue, we focused on screening cytotoxicity of polymers widely used for the layer-by-layer assembly technique using human blood cells. Cytotoxicity at the early stage was investigated on twenty types of polymers (positively charged, negatively charged, or neutral) and ten combination forms via hemolysis, cell viability, and AnnexinV-FITC/PI staining assays. We determined their effects on the cell membrane depending on their surface chemistry by molecular dynamics simulations. Furthermore, the toxicity of LbL-assembled nanofilms was assessed by measuring cell viability. Based on this report, researchers can produce nanofilms that are better suited for drug delivery and biomedical applications by reducing the possible cytotoxicity.

AB - Biocompatible polymers have been extensively applied to molecular assembly techniques on a micro- A nd nanoscale to miniaturize functional devices for biomedical uses. However, cytotoxic assessments of developed devices are prone to partially focus on non-specific cells or cells associated with the specific applications. Thereby, since toxicity is dependent on the type of cells and protocols, we do not fully understand the relative toxicities of polymers. Additionally, we need to ensure the blood cell biocompatibility of developed devices prior to that of targeted cells because most of the devices contact the blood before reaching the targeted regions. Motivated by this issue, we focused on screening cytotoxicity of polymers widely used for the layer-by-layer assembly technique using human blood cells. Cytotoxicity at the early stage was investigated on twenty types of polymers (positively charged, negatively charged, or neutral) and ten combination forms via hemolysis, cell viability, and AnnexinV-FITC/PI staining assays. We determined their effects on the cell membrane depending on their surface chemistry by molecular dynamics simulations. Furthermore, the toxicity of LbL-assembled nanofilms was assessed by measuring cell viability. Based on this report, researchers can produce nanofilms that are better suited for drug delivery and biomedical applications by reducing the possible cytotoxicity.

UR - http://www.scopus.com/inward/record.url?scp=85028302585&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028302585&partnerID=8YFLogxK

U2 - 10.1038/s41598-017-10169-5

DO - 10.1038/s41598-017-10169-5

M3 - Article

C2 - 28842713

AN - SCOPUS:85028302585

VL - 7

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 9481

ER -